Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AqualungCorp
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AqualungCorp
-
Prikvačeni tweet
Aqualung Therapeutics Corporation To Present New Data At Biotech Showcase Investor Conference https://buff.ly/2rjM4sf
#BTS20#biotech#ARDS#clinicaldata#inflammationpic.twitter.com/cGXwNYvGSz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aqualung - Developing Solutions to Unchecked Inflammatory Diseases https://buff.ly/34dbJ3x
#inflammation#ARDS#pulmonary#hypertension#prostate#cancerpic.twitter.com/kneQhp80nF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fluid intake-related association between urine output and mortality in acute respiratory distress syndrome https://buff.ly/2sXKUn8 pic.twitter.com/AOc0jcEKQA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Risk modifiers of acute respiratory distress syndrome in patients with non-pulmonary sepsis: a retrospective analysis of the FORECAST study https://buff.ly/2RNQ79r pic.twitter.com/Xegu3w2T9V
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aqualung awarded a $1.7M NIH Fast Track STTR Phase I/II grant https://buff.ly/34dbJ3x pic.twitter.com/qaXMVhYISB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Chorioamnionitis infection is a common complication of pregnancy https://buff.ly/34dbJ3x
#Chorioamnionitis#infection#pregnancy#neonatalpic.twitter.com/9nFYtD3oGu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Prognostic factors for ARDS: clinical, physiological and atypical immunodeficiency https://buff.ly/2TPB7dW
#ICU#criticalcare#ARDS#lung#injurypic.twitter.com/YipcaQpUv5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
VpALI—Vaping-related Acute Lung Injury: A New Killer Around the Block https://buff.ly/2NL1Fcn
#lung#injury#acutepic.twitter.com/stm4fR9o2p
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Advances in Pulmonary Hypertension: Exploring Atrial Septal Defect-Associated Pulmonary Hypertension https://buff.ly/2RcVLTv
#pulmonary#hypertensionpic.twitter.com/BSAnbMjnZH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aqualung - Developing Solutions to Unchecked Inflammatory Diseases https://buff.ly/34dbJ3x
#inflammation#ARDS#pulmonary#hypertension#prostate#cancerpic.twitter.com/j8Sp7cJdRT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Flow-Controlled Ventilation Attenuates Lung Injury https://buff.ly/2TL8E95
#VILI#lung#injurypic.twitter.com/oytcWv17yI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
#ARDS#ICU@JAMA_current#epidemiologypic.twitter.com/X20UxxSz1i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Acute Respiratory Distress Syndrome (ARDS)/Lung Failure https://buff.ly/3ajQr8q
#ARDS#lung#failurepic.twitter.com/Frl82HhJUw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aqualung Therapeutics, Corp proslijedio/la je Tweet
Thanks to all who have shared your time, your brilliance and your fork at the
#biotechshowcase#JPM20 week https://buff.ly/35WG9aM$SLRX$GOVX@AqualungCorp@phagomed@Quaralife@pacylex@LachesisBiosci1@Nanovalent_@SalariusPharma@Geovax_Newspic.twitter.com/Pgw9yiPKCH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
eNamptor™ is designed to limit activation of evolutionary inflammatory networks and to reduce mortality in serious inflammatory disorders. https://buff.ly/2LIIyyP
#investors#ARDS#collaborations#biotechshowcase#JPM20pic.twitter.com/wnSQ4vtDir
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you for a motivating conference! 2020 has a lot of potential! https://buff.ly/34dbJ3x
#inflammation#protein#prostatecancer#NAMPT#biotechshowcase#JPM20pic.twitter.com/sCLu8WQvxc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aqualung CEO Skip Garcia sharing clinical and under the radar
#critical#care injury through#inflamation.#biotechshowcase https://buff.ly/34dbJ3x pic.twitter.com/8DwJdWsASZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Science-driven approach identifies nicotinamide phosphoribosyltransferase (NAMPT) and other key proteins expressed in both acute and chronic inflammatory diseases https://buff.ly/34dbJ3x
#inflammation#protein#prostatecancer#NAMPT#biotechshowcasepic.twitter.com/YrW5LGeaUa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aqualung Presenting at Biotech Showcase https://bit.ly/34dbJ3x
#biotechshowcase#inflammation#protein#prostatecancer#NAMPTpic.twitter.com/TmPZMQq1D2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aqualung seeking $15M in Series A funding to manufacture its drug to treat inflammatory diseases https://buff.ly/36X8nDG
#BTS20#biotechshowcase#ARDS#clinicaldata#inflammationHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Presenting Today 9AM BTS Franciscan B. Aqualung will discuss eNamptor™designed to limit activation of evolutionary inflammatory networks and to reduce mortality in serious inflammatory disorders. https://buff.ly/2LIIyyP
#investors#ARDS#collaborations#biotechshowcasepic.twitter.com/yRzhXLfFvO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.